Invesco Ltd. trimmed its stake in BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 10.1% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 200,741 shares of the company’s stock after selling 22,575 shares during the quarter. Invesco Ltd.’s holdings in BlackRock Health Sciences Trust were worth $7,757,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. Ameriflex Group Inc. acquired a new position in shares of BlackRock Health Sciences Trust during the fourth quarter valued at about $41,000. Comerica Bank boosted its holdings in BlackRock Health Sciences Trust by 13.1% during the fourth quarter. Comerica Bank now owns 4,454 shares of the company’s stock worth $169,000 after purchasing an additional 517 shares during the last quarter. Fountainhead AM LLC purchased a new position in BlackRock Health Sciences Trust during the first quarter worth about $204,000. Oppenheimer & Co. Inc. boosted its holdings in BlackRock Health Sciences Trust by 8.4% during the first quarter. Oppenheimer & Co. Inc. now owns 6,295 shares of the company’s stock worth $243,000 after purchasing an additional 486 shares during the last quarter. Finally, Calamos Advisors LLC purchased a new position in BlackRock Health Sciences Trust during the first quarter worth about $251,000.
BlackRock Health Sciences Trust Stock Performance
BlackRock Health Sciences Trust stock opened at $36.50 on Tuesday. BlackRock Health Sciences Trust has a fifty-two week low of $34.18 and a fifty-two week high of $42.64. The firm’s 50-day simple moving average is $36.09 and its 200 day simple moving average is $37.04.
BlackRock Health Sciences Trust Announces Dividend
BlackRock Health Sciences Trust Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Trust
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Biotech Catalysts Present Major Opportunity
- Business Services Stocks Investing
- 3 Cheap Stocks That Shouldn’t Be This Low
- 3 Healthcare Dividend Stocks to Buy
- Why Sprouts Farmers Market is Buying $1 Billion of Its Own Stock
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.